-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule.
SUMMARY:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal approval of five new animal drug applications (NADAs) for roxarsone oral dosage form products at the sponsor's request because the products are no longer manufactured or marketed.
DATES:
Withdrawal of approval is effective January 6, 2014.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
John Bartkowiak, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9079, john.bartkowiak@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Zoetis Inc., 333 Portage St., Kalamazoo, MI 49007 has requested that FDA withdraw approval of the following five NADAs for roxarsone oral dosage form products, used to make medicated drinking water for chickens, turkeys, and swine, because the products are no longer manufactured or marketed:
NADA Proprietary name 005-414 REN-O-SAL (roxarsone) Tablets. 006-019 Zuco Poultry Tablets. 006-081 Korum Improved Formula. 008-274 Pig Scour Tablets. 093-025 3-NITRO (roxarsone) Soluble. Elsewhere in this issue of the Federal Register, FDA gave notice that approval of NADAs 005-414, 006-019, 006-081, 008-274, and 093-025, and all supplements and amendments thereto, is withdrawn, effective January 6, 2014. As provided in the regulatory text of this document, the animal drug regulations are amended to reflect these voluntary withdrawals of approval.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
Start List of SubjectsList of Subjects in 21 CFR Part 520
- Animal drugs
Therefore, under the Federal Food, Drug, and Cosmetic Act and under the authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is amended as follows:
Start PartPART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS
End Part Start Amendment Part1. The authority citation for 21 CFR part 520 continues to read as follows:
End Amendment Part[Removed]2. Remove §§ 520.2087, 520.2088, and 520.2089.
End Amendment Part Start SignatureDated: December 20, 2013.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2013-30838 Filed 12-26-13; 8:45 am]
BILLING CODE 4160-01-P0134
Document Information
- Effective Date:
- 1/6/2014
- Published:
- 12/27/2013
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule.
- Document Number:
- 2013-30838
- Dates:
- Withdrawal of approval is effective January 6, 2014.
- Pages:
- 78716-78716 (1 pages)
- Docket Numbers:
- Docket No. FDA-2013-N-0002
- Topics:
- Animal drugs
- PDF File:
- 2013-30838.pdf
- Supporting Documents:
- » FREEDOM OF INFORMATION SUMMARY NADA 130-185 AMPROL 25% and FLAVOMYCIN Amprolium and Bambermycins
- » FREEDOM OF INFORMATION SUMMARY Application Number 141-422 PACCAL VET-CA1 Paclitaxel for injection Powder for Injection Dog
- » FREEDOM OF INFORMATION SUMMARY NADA141-420 TILDREN tiludronate disodium Powder for injection Horse
- » FREEDOM OF INFORMATION SUMMARY NADA 141-361 PULMOTIL AC Tilmicosin Phosphate Aqueous Concentrate Swine
- » FREEDOM OF INFORMATION SUMMARY NADA 141-246 AQUAFLOR Florfenicol
- » Freedom of Information Summary NADA 141-288 EXCENEL RTU EZ Ceftiofur Hydrochloride
- » Freedom of Information Summary NADA 095-735 RUMENSIN 90 Monensin
- » Freedom of Information Summary NADA 141-406 NEXGARD Afoxolaner Chewable Tablet
- » Freedom of Information Summary ANADA 200-548 ACTOGAIN 45 Ractopamine Hydrochloride Cattle fed in confinement for slaughter
- » Freedom of Information Summary ANADA 200-542 ENGAIN 9 and ENGAIN 5 Ractopamine Hydrochloride Finishing Swine
- CFR: (1)
- 21 CFR 520.2087, 520.2088, and 520.2089